VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Exploiting antitumor immunity to overcome relapse and improve remission duration.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exploiting antitumor immunity to overcome relapse and improve remission duration.
Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother. 2012 Jul; 61(7):1113-24.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Benzamides
Disease-Free Survival
Gastrointestinal Neoplasms
Gastrointestinal Stromal Tumors
Humans
Imatinib Mesylate
Immunotherapy
Interferon-alpha
Interferon-gamma
Lymphocytes
Middle Aged
Piperazines
Polyethylene Glycols
Pyrimidines
Recombinant Proteins
Recurrence
T-Lymphocytes, Cytotoxic
authors with profiles
SHREYASKUMAR PATEL
PATRICK P LIN
ALEXANDER LAZAR